Fiduciary/Claymore Infrastructure FundのEBITDA margin
Fiduciary/Claymore Infrastructure FundのEBITDA marginは何ですか。
Fiduciary/Claymore Energy Infrastructure FundのEBITDA marginは-466.20%です。
EBITDA marginの定義は何ですか。
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
NYSEのセクタFinanceにおけるEBITDA marginの企業と比べるFiduciary/Claymore Infrastructure Fund
Fiduciary/Claymore Infrastructure Fundは何をしますか。
Fiduciary/Claymore Energy Infrastructure Fund is a closed ended equity mutual fund launched and managed by Guggenheim Funds Investment Advisors, LLC.
Fiduciary/Claymore Infrastructure Fundと類似のebitda margin
- Theralase TechnologiesのEBITDA marginは-476.04%です。
- Sangamo Therapeutics IncのEBITDA marginは-474.14%です。
- Xinyang MaojianのEBITDA marginは-471.45%です。
- WANdisco PlcのEBITDA marginは-470.42%です。
- RYU ApparelのEBITDA marginは-468.27%です。
- Barra ResourcesのEBITDA marginは-466.28%です。
- Fiduciary/Claymore Infrastructure FundのEBITDA marginは-466.20%です。
- SRAX IncのEBITDA marginは-465.79%です。
- Xtract One Technolgies IncのEBITDA marginは-464.36%です。
- Spruce BiosciencesのEBITDA marginは-462.16%です。
- Sage Therapeutics IncのEBITDA marginは-460.83%です。
- Arcimoto IncのEBITDA marginは-460.40%です。
- Canopy RiversのEBITDA marginは-458.36%です。